Malley A, Burger D R, Vandenbark A A, Frikke M, Finke P, Begley D, Acott K, Black J, Vetto R M
Cancer Res. 1979 Feb;39(2 Pt 2):619-23.
The majority of melanoma tumor antigen activity present in melanoma extracts derived from fresh tumor tissue binds to a Sepharose-anti-beta2-microglobulin adsorbent. Removal of HLA antigens from the extracts of melanoma tissue by using a KBr flotation technique did not reduce either the tumor antigen activity of the extracts or the binding of melanoma tumor antigen (MTA) activity to the Sepharose-anti-beta2-microglobulin adsorbent. The complete blocking of MTA activity by pretreating the anti-beta2-microglobulin adsorbent with beta2-microglobulin and the lack of detectable MTA binding to a Sepharose anti-normal human serum adsorbent demonstrated the specificity of the binding of MTA to the anti-beta2-microglobulin adsorbent.
从新鲜肿瘤组织中提取的黑色素瘤提取物中存在的大多数黑色素瘤肿瘤抗原活性与琼脂糖-抗β2-微球蛋白吸附剂结合。通过使用KBr浮选技术从黑色素瘤组织提取物中去除HLA抗原,既没有降低提取物的肿瘤抗原活性,也没有降低黑色素瘤肿瘤抗原(MTA)活性与琼脂糖-抗β2-微球蛋白吸附剂的结合。用β2-微球蛋白预处理抗β2-微球蛋白吸附剂可完全阻断MTA活性,且未检测到MTA与琼脂糖抗正常人血清吸附剂的结合,这证明了MTA与抗β2-微球蛋白吸附剂结合的特异性。